Mercuri, Eugenio Maria
 Distribuzione geografica
Continente #
EU - Europa 9.417
NA - Nord America 8.960
AS - Asia 2.171
SA - Sud America 62
AF - Africa 49
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.695
Nazione #
US - Stati Uniti d'America 8.893
DE - Germania 2.739
IT - Italia 1.830
SE - Svezia 1.561
CN - Cina 1.130
IE - Irlanda 680
UA - Ucraina 651
FR - Francia 498
SG - Singapore 453
GB - Regno Unito 342
RU - Federazione Russa 317
IN - India 223
FI - Finlandia 216
PL - Polonia 167
TR - Turchia 89
BE - Belgio 74
IR - Iran 67
CZ - Repubblica Ceca 65
NL - Olanda 54
HK - Hong Kong 52
JP - Giappone 47
CH - Svizzera 43
ES - Italia 40
CA - Canada 37
CI - Costa d'Avorio 31
AU - Australia 26
BR - Brasile 26
RO - Romania 22
KR - Corea 18
AT - Austria 17
IL - Israele 16
PH - Filippine 16
PA - Panama 15
AR - Argentina 14
EG - Egitto 14
RS - Serbia 13
MK - Macedonia 12
PT - Portogallo 10
CL - Cile 9
DK - Danimarca 9
HU - Ungheria 8
MX - Messico 8
NO - Norvegia 8
VN - Vietnam 8
A2 - ???statistics.table.value.countryCode.A2??? 7
GR - Grecia 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 7
BD - Bangladesh 6
CO - Colombia 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
HR - Croazia 5
MY - Malesia 5
PE - Perù 5
TW - Taiwan 4
EE - Estonia 3
ID - Indonesia 3
KZ - Kazakistan 3
LT - Lituania 3
PK - Pakistan 3
PR - Porto Rico 3
TH - Thailandia 3
AL - Albania 2
BT - Bhutan 2
HN - Honduras 2
LK - Sri Lanka 2
MA - Marocco 2
ME - Montenegro 2
MO - Macao, regione amministrativa speciale della Cina 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GL - Groenlandia 1
IS - Islanda 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
SM - San Marino 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.695
Città #
Chandler 2.032
Ashburn 843
Dublin 634
New York 439
Jacksonville 405
San Mateo 375
Rome 297
Nanjing 264
Singapore 260
Wilmington 254
Milan 247
Moscow 223
Marseille 212
Boston 209
Ann Arbor 192
Dearborn 185
Nürnberg 177
Woodbridge 159
Princeton 154
Houston 149
Warsaw 145
Fairfield 135
Munich 134
Lawrence 127
Redwood City 114
Seattle 113
Beijing 108
Bremen 103
Cattolica 99
Nanchang 97
Chicago 76
Redmond 76
Los Angeles 72
Lancaster 67
Hebei 65
Norwalk 63
Boardman 60
Brussels 59
Helsinki 56
Izmir 53
Detroit 51
Mountain View 50
Shenyang 50
Brno 48
Pune 45
Augusta 44
Jiaxing 44
University Park 42
Changsha 41
Hong Kong 41
Kish 40
Jinan 38
Shanghai 38
Leawood 37
Palermo 36
Cambridge 33
Hangzhou 33
Abidjan 31
Kunming 31
Tianjin 31
Zhengzhou 30
Guangzhou 28
Washington 28
Andover 26
Busto Arsizio 26
Florence 26
London 25
Fremont 24
Toronto 23
Edinburgh 22
Bologna 19
Turin 19
Ningbo 18
San Francisco 16
Bari 15
Hefei 15
Sydney 15
Urbino 15
Messina 14
Monza 14
Inverigo 13
Lappeenranta 13
Madrid 13
Menlo Park 13
Seoul 13
Simi Valley 13
São Paulo 13
Amsterdam 12
Naples 12
Philadelphia 12
San Diego 12
Stockholm 12
Zurich 12
Catania 11
Frankfurt am Main 11
Prague 11
Tokyo 11
Bern 10
Clearwater 10
Padova 10
Totale 10.991
Nome #
Tele-riabilitazione con il Training Lettura Ritmica: Applicazione a distanza di un training ritmico-musicale per il potenziamento della lettura nella dislessia evolutiva 286
The visual function assessment: from birth to the follow up 265
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 252
Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module 209
Cortical visual function in preterm infants in the first year. 204
Enhanced human brain associative plasticity in Costello syndrome 191
Neurological examination of preterm infants a term equivalent age 184
Spinal muscular atrophy 184
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 161
Crossed cerebellar atrophy of prenatal onset 156
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 155
Prognostic value of EEG performed at term age in preterm infants. 150
Sleep-potentiated epileptiform activity in early thalamic injuries: Study in a large series (60 cases) 150
Application of a neonatal assessment of visual function in a population of low risk full-term newborn. 142
Use of the Hammersmith Infant Neurological Examination in Infants With Cerebral Palsy: A Critical Review of the Literature 140
Hammersmith Infant Neurological Examination in infants born at term: Predicting outcomes other than cerebral palsy 138
-Thalamic atrophy in infants with PVL and cerebral visual impairment 136
Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature. 127
Longitudinal assessment of perceptual-motor abilities in pre-school preterm children 125
Visual development in prenatal post-haemorragic ventricular dilatation 121
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 121
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 120
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standards of Care? 120
External hydrocephalus in discordant birth weight twins: a case report 119
Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome 118
Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation 116
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 115
Muscle MRI in Becker muscular dystrophy 113
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 112
Early assessment of visual function in preterm infants: how early is early? 109
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 109
Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 months. 108
Development of clinical signs in low risk term born infants with neonatal hyperexcitability 107
DMD myogenic cells from urine-derived stem cells recapitulate the dystrophin genotype and phenotype 107
Performance of Upper Limb module for Duchenne muscular dystrophy 107
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients 106
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 106
Neuropsychological development in children with Dravet syndrome. 104
134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands. 102
Neuropsychological development in children with Dravet syndrome 101
Muscle MRI in Becker muscular dystrophy 99
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 99
Long Term Memory Profile of Disorders Associated with Dysregulation of the RAS-MAPK Signaling Cascade. 98
A current approach to heart failure in Duchenne muscular dystrophy 98
Congenital muscular dystrophies with cognitive impairment. A population study 97
Perceptual-motor abilities in pre-school preterm children 97
Muscle MRI: Out of the tunnel. 96
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 96
Salbutamol increases serviva motor neuron (SMN) patients: relevance for clinical trial design 96
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study 96
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 95
Revised upper limb module for spinal muscular atrophy: Development of a new module 95
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy 95
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine 94
Neuropsychological development in children with Dravet syndrome 94
Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients 94
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 91
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 91
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 91
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy 90
209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands 89
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 86
FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion 85
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 85
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. 84
Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies 84
Application of a neonatal assessment of visual function in a population of low risk full-term newborn 83
Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report 83
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 83
Visual and visuoperceptual function in children with Panayiotopoulos syndrome 82
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 82
MRI: Out of the tunnel. 81
Assessing Joint Hypermobility in Preschool-Aged Children 80
Predominant distal muscle involvement in spinal muscular atrophy 80
The empowerment of translational research: lessons from laminopathies 80
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 79
Developmental milestones in type I spinal muscular atrophy 77
Calf muscle involvement in Becker muscular dystrophy: When size does not matter 76
Behavioral profile in RASopathies 76
Cognitive-behavioral profiles in teenagers with Dravet syndrome 76
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen 75
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 75
Childhood spinal muscular atrophy: controversies and challenges 74
Early Childhood Attention Battery: Italian adaptation and new expanded normative data. 74
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 74
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening 73
Auditory processing in infancy: do early abnormalities predict disorders of language and cognitive development? 71
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 71
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 71
Early visual and neuro-development in preterm infants with and without retinopathy 70
Predictive models in SMA II natural history trajectories using machine learning: A proof of concept study 70
Visual function assessment in late-preterm newborns. 69
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 69
Sleep-potentiated epileptiform activity in early thalamic injuries: Study in a large series (60 cases) 69
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 69
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 69
Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era 69
173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands 68
Application of the Sleep Disturbance Scale for Children (SDSC) in infants and toddlers (6–36 months) 68
Early Childhood Attention Battery: Italian adaptation and new expanded normative data. 67
Totale 10.644
Categoria #
all - tutte 96.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.166 502 103 124 92 134 188 246 88 107 142 289 151
2020/20211.578 73 163 31 138 200 137 211 43 209 90 262 21
2021/20222.605 221 137 75 185 140 104 52 417 144 178 468 484
2022/20236.206 713 764 452 923 398 774 377 538 754 88 254 171
2023/20244.498 185 913 143 292 171 707 473 202 108 228 447 629
2024/2025169 169 0 0 0 0 0 0 0 0 0 0 0
Totale 21.153